Walensky: FDA working to OK Pfizer, Moderna COVID booster shots for certain immunocompromised patients
The Food and Drug Administration (FDA) is rapidly approaching a potential authorization for a third dose of Pfizer’s and Moderna’s COVID-19 vaccines among certain immunocompromised patients, within the next day, Dr. Rochelle Walensky, head of the Centers for Disease Control and Prevention (CDC) said Thursday.